Shopping Cart 0
Cart Subtotal
USD 0

City of Hope-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation services and pathology, among others. It conducts research and development to develop treatments for cancer fighting drugs, avastin, herceptin, and rituxan. COH also offers educational services for post doctoral fellowships through its affiliates. The organization also provides clinical trial services. Its community practice site includes Arcadia, Corona, Mission Hills, Arcadia Radiation Oncology, Santa Clarita, Palm Springs, Simi Valley, Colton, Glendora, Pasadena, and others. The orgaization operates in Duarte, Rancho Cucamonga, Simi Valley, Santa Clarita, Mission Hills, Pasadena, Arcadia, Glendora, and West Covina. COH is headquartered in Duarte, California, the US.

City of Hope-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

City of Hope, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Coronado Biosciences Forms Joint Venture with City of Hope 11

ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 11

Licensing Agreements 12

Mustang Bio Enters into Licensing Agreement with City of Hope 12

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 13

City of Hope Signs Licensing Agreement with Homology Medicines 14

Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 14

Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 15

Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 16

Novonco Pharma Enters into Licensing Agreement with City of Hope 17

Helocyte Exercises Option for Licensing Agreement with City of Hope 17

ES Cell International Enters into Licensing Agreement with Beckman Research Institute 18

Helocyte Enters into Licensing Agreement with City of Hope 19

Mustang Bio Enters into Licensing Agreement with City of Hope 19

City of Hope-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 26

Government and Public Interest 26

Apr 17, 2017: City Of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study 26

Mar 07, 2017: Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations 28

Sep 12, 2016: Semma Therapeutics Announces $5 Million Grant from California Institute of Regenerative Medicine to Develop Novel Stem-Cell Derived Treatment for Diabetes 29

Jun 29, 2016: Study Recommends Genomic Profiling to Diagnose Nonsmall Cell Lung Cancer Subtypes 30

Apr 03, 2016: Salmonella-Based Oral Vaccine Is A Potential Therapy For Preventing Type 1 Diabetes 32

Mar 31, 2016: City Of Hope awarded $2.5 million grant by the Conrad N. Hilton Foundation to launch nutrition initiative 33

Mar 16, 2016: City of Hope Research Team Receives $7.38 Million Grant from California's Stem Cell Agency 35

Mar 03, 2016: City of Hope, Israel Cancer Research Fund Create Program for Cancer Research 36

Feb 08, 2016: City of Hope Scientists Create Technology to Target 'Undruggable' Diseases 37

Jan 21, 2016: City of Hope Receives $12 Million NCI Grant Supporting Innovative Cloud-Based Approach 38

Product News 39

May 01, 2017: City of Hope Researchers Find Regular Use of Aspirin Can Lower Risk of Breast Cancer for Women 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

City of Hope, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9


List Of Table

List of Tables

City of Hope, Pharmaceuticals & Healthcare, Key Facts 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Deals By Therapy Area, 2011 to YTD 2017 9

City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Coronado Biosciences Forms Joint Venture with City of Hope 11

ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 11

Mustang Bio Enters into Licensing Agreement with City of Hope 12

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 13

City of Hope Signs Licensing Agreement with Homology Medicines 14

Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 14

Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 15

Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 16

Novonco Pharma Enters into Licensing Agreement with City of Hope 17

Helocyte Exercises Option for Licensing Agreement with City of Hope 17

ES Cell International Enters into Licensing Agreement with Beckman Research Institute 18

Helocyte Enters into Licensing Agreement with City of Hope 19

Mustang Bio Enters into Licensing Agreement with City of Hope 19

City of Hope, Key Competitors 21

City of Hope, Key Employees 22

City of Hope, Other Locations 24

City of Hope, Subsidiaries 24

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

City of Hope, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

City of Hope (COH) is a biomedical research organization that offers cancers, diabetes and infectious diseases treatment services. The organization offers services in the fields of anesthesiology, interventional radiology, surgery, donor matching and marrow transplants, rehabilitation services and pathology, among others. It conducts research and development to develop treatments for cancer fighting drugs, avastin, herceptin, and rituxan. COH also offers educational services for post doctoral fellowships through its affiliates. The organization also provides clinical trial services. Its community practice site includes Arcadia, Corona, Mission Hills, Arcadia Radiation Oncology, Santa Clarita, Palm Springs, Simi Valley, Colton, Glendora, Pasadena, and others. The orgaization operates in Duarte, Rancho Cucamonga, Simi Valley, Santa Clarita, Mission Hills, Pasadena, Arcadia, Glendora, and West Covina. COH is headquartered in Duarte, California, the US.

City of Hope-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

City of Hope, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Coronado Biosciences Forms Joint Venture with City of Hope 11

ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 11

Licensing Agreements 12

Mustang Bio Enters into Licensing Agreement with City of Hope 12

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 13

City of Hope Signs Licensing Agreement with Homology Medicines 14

Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 14

Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 15

Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 16

Novonco Pharma Enters into Licensing Agreement with City of Hope 17

Helocyte Exercises Option for Licensing Agreement with City of Hope 17

ES Cell International Enters into Licensing Agreement with Beckman Research Institute 18

Helocyte Enters into Licensing Agreement with City of Hope 19

Mustang Bio Enters into Licensing Agreement with City of Hope 19

City of Hope-Key Competitors 21

Key Employees 22

Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 26

Government and Public Interest 26

Apr 17, 2017: City Of Hope Researchers Successfully Prevent Graft-Versus-Host Disease While Preserving Strong Graft Versus Leukemia Effects In Preclinical Study 26

Mar 07, 2017: Researchers Study Cure for Type 1 Diabetes in Stem Cell Transplantations 28

Sep 12, 2016: Semma Therapeutics Announces $5 Million Grant from California Institute of Regenerative Medicine to Develop Novel Stem-Cell Derived Treatment for Diabetes 29

Jun 29, 2016: Study Recommends Genomic Profiling to Diagnose Nonsmall Cell Lung Cancer Subtypes 30

Apr 03, 2016: Salmonella-Based Oral Vaccine Is A Potential Therapy For Preventing Type 1 Diabetes 32

Mar 31, 2016: City Of Hope awarded $2.5 million grant by the Conrad N. Hilton Foundation to launch nutrition initiative 33

Mar 16, 2016: City of Hope Research Team Receives $7.38 Million Grant from California's Stem Cell Agency 35

Mar 03, 2016: City of Hope, Israel Cancer Research Fund Create Program for Cancer Research 36

Feb 08, 2016: City of Hope Scientists Create Technology to Target 'Undruggable' Diseases 37

Jan 21, 2016: City of Hope Receives $12 Million NCI Grant Supporting Innovative Cloud-Based Approach 38

Product News 39

May 01, 2017: City of Hope Researchers Find Regular Use of Aspirin Can Lower Risk of Breast Cancer for Women 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

City of Hope, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9


List Of Table

List of Tables

City of Hope, Pharmaceuticals & Healthcare, Key Facts 1

City of Hope, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

City of Hope, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

City of Hope, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

City of Hope, Deals By Therapy Area, 2011 to YTD 2017 9

City of Hope, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Coronado Biosciences Forms Joint Venture with City of Hope 11

ModiQuest Research Enters Into Research Agreement With Beckman Research Institute 11

Mustang Bio Enters into Licensing Agreement with City of Hope 12

Akriveia Therapeutics Enters into Licensing Agreement with City of Hope and Thomas Jefferson University 13

City of Hope Signs Licensing Agreement with Homology Medicines 14

Beckman Research Institute Enters into Licensing Agreement with CEVEC Pharma 14

Tara Immuno-Oncology Therapeutics Enters into Licensing Agreement with City of Hope 15

Sorrento Therapeutics Enters into Licensing Agreement with City of Hope 16

Novonco Pharma Enters into Licensing Agreement with City of Hope 17

Helocyte Exercises Option for Licensing Agreement with City of Hope 17

ES Cell International Enters into Licensing Agreement with Beckman Research Institute 18

Helocyte Enters into Licensing Agreement with City of Hope 19

Mustang Bio Enters into Licensing Agreement with City of Hope 19

City of Hope, Key Competitors 21

City of Hope, Key Employees 22

City of Hope, Other Locations 24

City of Hope, Subsidiaries 24

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

City of Hope, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.